CA1216850A - Pyridylalkyl nitrate compound, process for preparation thereof and pharmaceutical composition comprising the same - Google Patents
Pyridylalkyl nitrate compound, process for preparation thereof and pharmaceutical composition comprising the sameInfo
- Publication number
- CA1216850A CA1216850A CA000433162A CA433162A CA1216850A CA 1216850 A CA1216850 A CA 1216850A CA 000433162 A CA000433162 A CA 000433162A CA 433162 A CA433162 A CA 433162A CA 1216850 A CA1216850 A CA 1216850A
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- hydrogen
- compound
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8221592 | 1982-07-26 | ||
| GB8221592 | 1982-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1216850A true CA1216850A (en) | 1987-01-20 |
Family
ID=10531922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000433162A Expired CA1216850A (en) | 1982-07-26 | 1983-07-26 | Pyridylalkyl nitrate compound, process for preparation thereof and pharmaceutical composition comprising the same |
Country Status (17)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
| JPS6215A (ja) * | 1985-02-26 | 1987-01-06 | Fujisawa Pharmaceut Co Ltd | ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤 |
| ZA885069B (en) * | 1987-07-24 | 1989-03-29 | Fujisawa Pharmaceutical Co | Sustained-release percutaneous preparations |
| JPH02167279A (ja) * | 1988-09-30 | 1990-06-27 | Taisho Pharmaceut Co Ltd | アポビンカミン酸誘導体 |
| US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
| CN106318877A (zh) * | 2016-08-29 | 2017-01-11 | 刘翔 | 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3275642A (en) * | 1962-04-26 | 1966-09-27 | Bard Pharmaceutical Inc | 3-pyridine carbinol nitrate and its preparation |
| US3689494A (en) * | 1971-03-31 | 1972-09-05 | William R J Simpson | N-pyridinealkyl-alkanolamine nitrates |
-
1983
- 1983-07-05 DK DK311683A patent/DK311683A/da not_active Application Discontinuation
- 1983-07-07 FI FI832490A patent/FI832490L/fi not_active Application Discontinuation
- 1983-07-07 AU AU16635/83A patent/AU565791B2/en not_active Ceased
- 1983-07-11 ZA ZA835048A patent/ZA835048B/xx unknown
- 1983-07-11 GR GR71903A patent/GR78629B/el unknown
- 1983-07-19 JP JP58132645A patent/JPS5951263A/ja active Granted
- 1983-07-20 PH PH29255A patent/PH18083A/en unknown
- 1983-07-20 US US06/515,653 patent/US4540701A/en not_active Expired - Fee Related
- 1983-07-22 ES ES524375A patent/ES524375A0/es active Granted
- 1983-07-23 EP EP83107232A patent/EP0100081B1/en not_active Expired
- 1983-07-23 AT AT83107232T patent/ATE40948T1/de not_active IP Right Cessation
- 1983-07-23 DE DE8383107232T patent/DE3379255D1/de not_active Expired
- 1983-07-25 SU SU833625197A patent/SU1189337A3/ru active
- 1983-07-25 NO NO832700A patent/NO832700L/no unknown
- 1983-07-25 HU HU832615A patent/HU190497B/hu unknown
- 1983-07-26 CA CA000433162A patent/CA1216850A/en not_active Expired
- 1983-07-26 KR KR1019830003459A patent/KR900005470B1/ko active IP Right Grant
-
1985
- 1985-05-08 US US06/731,893 patent/US4613608A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4540701A (en) | 1985-09-10 |
| DE3379255D1 (en) | 1989-04-06 |
| AU1663583A (en) | 1984-02-02 |
| FI832490L (fi) | 1984-01-27 |
| KR840005426A (ko) | 1984-11-12 |
| US4613608A (en) | 1986-09-23 |
| SU1189337A3 (ru) | 1985-10-30 |
| DK311683D0 (da) | 1983-07-05 |
| GR78629B (US06291489-20010918-C00077.png) | 1984-09-27 |
| ZA835048B (en) | 1984-03-28 |
| HU190497B (en) | 1986-09-29 |
| NO832700L (no) | 1984-02-06 |
| ATE40948T1 (de) | 1989-03-15 |
| FI832490A0 (fi) | 1983-07-07 |
| PH18083A (en) | 1985-03-18 |
| EP0100081A3 (en) | 1985-05-02 |
| ES8502088A1 (es) | 1984-12-16 |
| AU565791B2 (en) | 1987-10-01 |
| JPS6350343B2 (US06291489-20010918-C00077.png) | 1988-10-07 |
| EP0100081B1 (en) | 1989-03-01 |
| JPS5951263A (ja) | 1984-03-24 |
| EP0100081A2 (en) | 1984-02-08 |
| KR900005470B1 (ko) | 1990-07-30 |
| ES524375A0 (es) | 1984-12-16 |
| DK311683A (da) | 1984-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5273986A (en) | Cycloalkylthiazoles | |
| EP0553191B1 (en) | Pyridine and pyridine n-oxide derivatives of diarylmethyl- piperidines or piperazines, compositions and use thereof | |
| US5519038A (en) | N,N'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamines | |
| JP2000509408A (ja) | ２−アミノ−６−（２−置換−４−フェノキシ）−置換ピリジン | |
| JP4664673B2 (ja) | Ｎｏｓ阻害活性を有するアミノベンゾチアゾール化合物 | |
| FR2656610A1 (fr) | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. | |
| WO2003006670A2 (en) | 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors | |
| CA1216850A (en) | Pyridylalkyl nitrate compound, process for preparation thereof and pharmaceutical composition comprising the same | |
| RU2235095C2 (ru) | 2,3-дизамещенное производное пиридина, способы его получения, содержащая его фармацевтическая композиция и промежуточный продукт для его получения | |
| US4063025A (en) | 4-Substituted amino-α-aminomethylbenzyl alcohol derivatives | |
| EP0642514B1 (en) | Bridged bis-aryl carbinol derivatives, compositions and methods of use | |
| US5134151A (en) | 2-picolylamine derivatives | |
| US4404214A (en) | 2-Pyridinecarboxamide derivatives compositions containing same and method of using same | |
| US4556739A (en) | 3,4-Dialkoxy-2-alkylcarbonyl analino compounds | |
| HU218274B (en) | N,n'-bis hydroxyalkyl and alkoxyalkyl-pyridine-2,4-dicarboxylic acid diamide derivatives and pharmaceutical compositions comprising such compounds and process for producing them | |
| EP0977723B1 (en) | Process for the preparation of trifluoroethoxyarenecarboxylic acids | |
| EP0312040B1 (en) | 2,4-disubstituted derivatives of tetrahydrofuran | |
| FR2486076A1 (fr) | Aminocyclopentanone amides, leur preparation et compositions pharmaceutiques qui les contiennent | |
| US4820723A (en) | Disubstituted tetrazole leukotriene antagonists and methods for their use thereas | |
| US4160828A (en) | Analgesic phosphinyl compounds and compositions | |
| HU202506B (en) | Process for producing benzoxazolone derivatives | |
| JPH02275846A (ja) | カルボン酸誘導体 | |
| JPH01221365A (ja) | 化合物の新規な製造方法 | |
| EP0076600A1 (en) | Anthranilic acid esters | |
| US4208415A (en) | 4-[2-(2-Substituted phenyl)ethenyl]-N-alkenyl or alkinyl substituted 1,2,3,6-tetrahydropyridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |